Expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in endometriosis

In: Di-san junyi daxue xuebao · 2005 · W2367922954
article OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex
AI-generated summary by claude@2026-06, 2026-06-12

This study found that higher MMP-2 and lower TIMP-2 expression in ectopic endometriotic tissues contribute to increased invasion capacity and play a role in endometriosis pathogenesis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objective To investigate the role of matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) in the pathogenesis of endometriosis. Methods Immunohistochemical S-P method was employed to detect the expression of MMP-2 and TIMP-2 in the ectopic tissues and eutopic endometrium of 22 patients with endometriosis and 20 normal controls. Results The expression of MMP-2 in glandular cells was significantly higher than those of uterine endometrium from women with and without endometriosis (P0.01). The expression of TIMP-2 in the ectopic tissue was lower than that of the eutopic endometrium from women with endometriosis and the normal controls (P0.05). The expression of MMP-2 and TIMP-2 in eutopic endometrium showed no difference from that of the normal controls (P0.05). The expressions of MMP-2 and TIMP-2 were not related to the degree of endometriosis. Conclusion The increased expression of MMP-2 and the decreased expression of TIMP-2 in the ectopic endometriotic tissues result in the higher ratio of MMP-2/TIMP-2 that can make ectopic endometrial tissues have a greater capacity to invade and play an important role in the pathogenesis of endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK